EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance
Changhao Huang(Central South University), Zhikang Chen(Central South University)
Cited by 82
Related Papers
Expression Levels of Insulin-Like Growth Factor-1 and Multidrug Resistance-Associated Protein-1 Indicate Poor Prognosis in Patients with Gastric Cancer
|Digestion|2009|49
LXRα Promotes the Differentiation of Human Gastric Cancer Cells through Inactivation of Wnt/β-catenin Signaling
|Journal of Cancer|2018|11
Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma
|Clinical and Translational Medicine|2023|4